Journal: |
Non coding RNA Research
Elsevier
|
Volume: |
|
Abstract: |
Purpose: The role of the Sirutin 1 (SIRT1) and MicroRNA-34 a (miR-34a) in endometriosis and the extent to which
the miR-34a/SIRT1/p53 signaling pathway is involved in its pathogenesis is unclear, so we aimed to investigate
the expression of miRNA 34-a, SIRT1, Forkhead boxO (FoxO-1), p53 and other apoptotic markers in endometrial
tissue of women with endometriosis in order to better understand their role and the mechanisms of their actions
in the pathogenesis of such disease and if it is related to apoptosis or not.
Methods: Ectopic and eutopic endometriotic tissues were collected from seventy women with endometriosis while
normal endometrial tissues were obtained from 40 fertile women without endometriosis and then gene
expression of SIRT-1, miR-34a,p53, Bax, Bcl-2, Bcl-xL and FoxO-1 were measured using RT-PCR.
Results: We detected that SIRT-1 and Bcl-xL genes expressions was significantly up-regulated while miRNA34-a,
p53, Bax, Bcl-2 and FoxO-1 were down-regulated in endometrial tissue of endometriotic patients compared to
that of those without endometriosis. There was an inverse relationship between SIRT-1a, Bcl-xL genes expressions
and miR-34a, p53, Bax, Bcl-2 expressions as well as FoxO-1 expression. These results imply that miR-34a
might regulate p53 through SIRT-1 and subsequently FoxO-1 expression in endometriotic tissue, and so it can
contribute to the pathogenesis of endometriosis by decreasing the naturally occurring apoptosis in endometrium.
Conclusion: This study may provide a potential biomarker for endometriosis therapeutics. Identification of target
genes downstream of these transcriptional factors would allow better understanding of their respective roles in
the pathogenesis of endometriosis.
|
|
|